Literature DB >> 8097688

Nonlinear pharmacokinetics of cefadroxil in the rat.

M C García-Carbonell1, L Granero, F Torres-Molina, J C Aristorena, J Chesa-Jiménez, J M Plá-Delfina, J E Peris-Ribera.   

Abstract

The pharmacokinetics and bioavailability of cefadroxil in the rat were examined after intravenous and oral administration at three doses (2.5, 10, and 15 mg). Cefadroxil disposition kinetics was clearly nonlinear, with an increase in plasma clearance as the dose increased (2.65 +/- 0.55, 3.17 +/- 0.48, and 3.82 +/- 0.39 ml/min for the three doses assayed). This phenomenon was attributed to a saturable renal tubular reabsorption of the antibiotic. After oral administration, the normalized Cmax was lower for the largest dose (4.6 +/- 0.7 micrograms/ml) than for the other two doses (5.5 +/- 0.5 and 5.4 +/- 0.7 micrograms/ml). Renal excretion of cefadroxil in the rat after intravenous and oral administration was investigated at two level doses (2.5 and 15 mg). No significant differences were found between doses or administration routes, and the mean percentage of dose recovered in the urine for the intravenous and oral routes was 80.7 +/- 6.1% and 76.4 +/- 3.7%, respectively. Cefadroxil bioavailability estimated from plasma levels or from the amounts of drug excreted in the urine was high and ranged from 90% to 100%.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8097688

Source DB:  PubMed          Journal:  Drug Metab Dispos        ISSN: 0090-9556            Impact factor:   3.922


  8 in total

1.  In vivo absorption and disposition of cefadroxil after escalating oral doses in wild-type and PepT1 knockout mice.

Authors:  Maria M Posada; David E Smith
Journal:  Pharm Res       Date:  2013-11       Impact factor: 4.200

2.  Low bioavailability of amoxicillin in rats as a consequence of presystemic degradation in the intestine.

Authors:  J Chesa-Jiménez; J E Peris; F Torres-Molina; L Granero
Journal:  Antimicrob Agents Chemother       Date:  1994-04       Impact factor: 5.191

3.  Population pharmacokinetic modeling of cefadroxil renal transport in wild-type and Pept2 knockout mice.

Authors:  Yehua Xie; Hong Shen; Yongjun Hu; Meihua Rose Feng; David E Smith
Journal:  Xenobiotica       Date:  2015-09-15       Impact factor: 1.908

4.  Species differences in the pharmacokinetics of cefadroxil as determined in wildtype and humanized PepT1 mice.

Authors:  Yongjun Hu; David E Smith
Journal:  Biochem Pharmacol       Date:  2016-03-12       Impact factor: 5.858

5.  Impact of lipopolysaccharide-induced inflammation on the disposition of the aminocephalosporin cefadroxil.

Authors:  Yeamin Huh; Richard F Keep; David E Smith
Journal:  Antimicrob Agents Chemother       Date:  2013-09-30       Impact factor: 5.191

6.  Effect of transporter inhibition on the distribution of cefadroxil in rat brain.

Authors:  Xiaomei Chen; Irena Loryan; Maryam Payan; Richard F Keep; David E Smith; Margareta Hammarlund-Udenaes
Journal:  Fluids Barriers CNS       Date:  2014-11-14

7.  Physiologically Based Pharmacokinetic Modeling of Cefadroxil in Mouse, Rat, and Human to Predict Concentration-Time Profile at Infected Tissue.

Authors:  Zhongxia Tan; Youxi Zhang; Chao Wang; Le Sun
Journal:  Front Pharmacol       Date:  2021-12-23       Impact factor: 5.810

Review 8.  Scaling basic toxicokinetic parameters from rat to man.

Authors:  K Bachmann; D Pardoe; D White
Journal:  Environ Health Perspect       Date:  1996-04       Impact factor: 9.031

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.